16 The agencies pointed out 17 that commenters also noted that enabling States to more easily and, perhaps, therefore, more frequently, update their EHB-benchmark plans could result in expanded coverage for, among other things, maternity care, substance use disorder care, obesity care, and chronic disease management. So while most current EHB benchmark plans do not include coverage for anti-obesity medications, that could certainly change in the coming years
Many GLP-1s are already FDA approved and physicians can legally prescribe them off-label for any use
It also has a way of making every skincare product you try feel completely useless
Tablets aim to give people another option, especially those who dislike needles or find injecting difficult
Carballo-CaslaAAvesaniCMBeridzeGOrtolRGarca-EsquinasELopez-GarciaEet al